U.S. Physical Therapy adds NYSE Texas listing

Published 28/05/2025, 21:22
U.S. Physical Therapy adds NYSE Texas listing

HOUSTON - U.S. Physical Therapy, Inc. (NYSE: USPH), a prominent national operator of outpatient physical therapy clinics with a market capitalization of $1.16 billion, has announced its common stock will now also be traded on NYSE Texas, alongside its primary listing on the New York Stock Exchange. This makes the Houston-based company, which has maintained strong financial health according to InvestingPro analysis, the first healthcare entity to join the ranks of NYSE Texas as a Founding Member.

Chris Reading, the Chairman and CEO of U.S. Physical Therapy, expressed pride in joining NYSE Texas and acknowledged the role of the company’s Texas roots in attracting talent and contributing to its nationwide growth. Chris Taylor, NYSE Group’s Chief Development Officer, welcomed USPH to NYSE Texas, highlighting the significance of their addition to the exchange’s founding members.

Established in 1990, U.S. Physical Therapy operates over 776 outpatient clinics across 44 states, providing a variety of services including orthopedic care, sports injury treatment, neurological injury rehabilitation, and industrial injury prevention. The company has demonstrated solid growth with revenue increasing by 14.3% in the last twelve months, while maintaining a consistent dividend payment track record of 15 consecutive years. The company’s industrial injury prevention division offers onsite services such as injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments. For deeper insights into USPH’s performance metrics and growth potential, investors can access comprehensive analysis through InvestingPro, which features additional ProTips and detailed financial metrics.

The dual listing on NYSE Texas reflects U.S. Physical Therapy’s commitment to the state’s economy and its role in the company’s success. The move is expected to enhance the company’s visibility in the financial markets and provide additional liquidity for its shareholders. USPH will continue to trade under the ticker symbol "USPH" on both the New York Stock Exchange and NYSE Texas.

This expansion into NYSE Texas is based on a press release statement from U.S. Physical Therapy, Inc. and does not incorporate information from the company’s website. As a new participant in this regional exchange, U.S. Physical Therapy marks a milestone as NYSE Texas continues to grow its community of founding members. The company’s stock has experienced a challenging year, with a total return of -22.96% over the past 12 months, though InvestingPro analysis indicates strong cash flows and sustainable dividend payments, with the current yield at 2.35%.

In other recent news, U.S. Physical Therapy Inc. reported its first-quarter 2025 earnings, surpassing market expectations with an earnings per share (EPS) of $0.48, compared to the forecasted $0.40. The company also exceeded revenue forecasts, achieving $183.79 million against an expected $177.3 million. Despite these positive earnings results, the company faced challenges such as Medicare rate cuts, which impacted profitability by approximately $20 million. Additionally, U.S. Physical Therapy expanded its physical therapy centers and enhanced its home care capabilities, adding 14 new centers and acquiring Metro, which contributed approximately $17 million in revenue.

The company recently held its annual shareholder meeting, where all eight director nominees were elected to the board, and shareholders approved the compensation of named executive officers. Furthermore, Grant Thornton LLP was ratified as the company’s independent registered public accounting firm for 2024. In terms of analyst activity, there were no recent upgrades or downgrades reported. These developments reflect U.S. Physical Therapy’s ongoing efforts to navigate industry challenges and maintain strong demand for its services.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.